Stock·NYSE·Consumer Cyclical
QuantumScape Corporation (QS)
- Market cap
- $2.48B
- Dividend yield
- 0.00%
- Street target
- $7.50median of 9 analysts
- 52-week range
- $3.80 $18.56
The short version
Where QS stands today, in four lines, and what CleaRank Financial AI makes of it.
QS at a glance
QuantumScape Corporation (QS): Sell, 24/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($5.22 and $6.99).
- Earnings QS beat estimates in 1 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $142.7M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates QuantumScape Corporation (QS) Sell, with a model score of 24/100.
The analysts' outlook lifts the score most: the median target is 86.6% above the price. The trend holds it back most: the price is 42.52% below its 200-day average and 23.02% below its 50-day average, and the 50-day average is 25.33% below the 200-day. The 50-day average stands at $5.22 and the 200-day at $6.99. Over the past year the price fell 74.00%.
Only on CleaRank
Figures we compute ourselves from QS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $4.02 is 23.0% below the 50-day simple moving average of $5.22.Price above its 200-day average ›
The price is 42.5% below the 200-day simple moving average of $6.99.50-day average above the 200-day ›
The 50-day average ($5.22) is 25.3% below the 200-day average ($6.99), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $3.80 and $18.56.
QS share price
Pick a period: each tab shows how far QS has moved over it, to the last close.
Today's trading
Where QS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/1Beat estimates in most recent reports ›
QS beat the EPS estimate in 1 of its last 7 reports.
Key statistics
The headline figures for QS.
As of October 17, 2026, QS trades at $4.02, with a market value of $2.48B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of QS's valuation, growth and risks.
QuantumScape Corporation (QS) has no meaningful P/E, because the company lost money over the last 12 months. To put that in scale, its trailing earnings stand at -$0.69 a share.
Profitability is absent for QS at present, with a net margin of 0.00% and an operating margin of 0.00%. Its return on equity of -39.08% sits below the sector median of 12.4%. QS also carries debt-to-equity of 0.06, which rounds out the balance sheet picture.
QS's most recent available report in our data, on February 11, 2026, missed the estimate by 0.00%, with -$0.17 a share against a -$0.17 estimate. Shares fell 11.96% in the next session.
QS beat the EPS estimate in 1 of its last 7 reports, and every one of those beats was followed by a gain the next day. The largest of the earlier reactions came after the October 22, 2025 report, which beat the estimate by 10.00% while the stock rose 7.95%. Analysts' average EPS estimate for this fiscal year is -$0.6689, and -$0.6806 for next year.
Day-to-day volatility is the first thing to plan around: QS has moved 3.18% on an average session. Until the price regains its moving averages, the trend works against holders. The price is 78.34% below its 52-week high of $18.56. Insiders sold $142.7M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
QS against the Consumer Cyclical sector
How QS compares with the median Consumer Cyclical stock CleaRank tracks.
Return vs SPY: Since May 6, 2025, QS has gained 3.3% against a gain of 36.6% for SPY.
Performance against SPY
QS and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much QS sells, and how much of it becomes profit.
Loss-making: QS lost $435M in FY2025.
Earnings reality check
Did QS beat what analysts expected, and how did the stock react?
Earnings record: QS beat the analyst estimate in 1 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Feb 11, 2026after close | -$0.17 | -$0.17 | +0.00% | -11.96% | -18.71% |
| Oct 22, 2025after close | -$0.20 | -$0.18 | +10.00% | +7.95% | +16.64% |
| Jul 23, 2025after close | -$0.18 | -$0.20 | -11.11% | -1.56% | -31.57% |
| Apr 23, 2025after close | -$0.19 | -$0.21 | -10.53% | -0.50% | -1.76% |
| Feb 12, 2025after close | -$0.21 | -$0.22 | -4.76% | +7.04% | +10.35% |
| Oct 23, 2024after close | -$0.19 | -$0.23 | -21.05% | +25.48% | +2.70% |
| Jul 24, 2024after close | -$0.18 | -$0.25 | -38.89% | -1.05% | +1.57% |
Reports after February 11, 2026 are not yet in our data.
As of October 17, 2026, QS has beaten the analyst EPS estimate in 1 of its last 7 reported quarters and rose in the first trading session after that beat; its most recent report in our data, on February 11, 2026, came in 0.00% above the estimate and the stock moved -11.96% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 31.1, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 31.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of QS
The score, the reasoning behind it, and what could move the price next.
QS is trending down. Trading at $4.02, the stock sits 23.02% below its 50-day average of $5.22 and 42.52% below its 200-day average of $6.99. Its position in the 52-week range is near the bottom: the price is 5.79% above the low of $3.80, while it remains 78.34% below the high of $18.56. Both averages point the same way, with the 50-day sitting 25.33% below the 200-day.
The 14-day RSI of 31.1 is in the bearish zone, above the oversold line, and the MACD line is negative. The record is negative across every period shown: the price fell 31.40% over the past three months, fell 43.38% over the past six months and fell 74.00% over the past year.
Rating reaffirmed ›
TD Cowen kept its Hold rating on July 24, 2026.
Source: Analyst action, TD Cowen, July 24, 2026
Earnings miss ›
The February 11, 2026 report missed the EPS estimate by 0.00%, and the share price fell 11.96% in the first session after it.
Source: Earnings report, February 11, 2026
- Two levels matter most: the 20-day EMA at $4.54, which sits above the price, and the 52-week low at $3.80, which sits below it.
- The 14-day RSI is 31.1, which falls in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- QS beat estimates in 1 of the last 7 reports. After the February 11, 2026 report, the share price dropped 11.96% in the first session.
QS sits below its 50-day and 200-day moving averages ($5.22 and $6.99), and that placement is why the trend reads down. A recovery would begin with a move back above the 50-day. The first level overhead is the 20-day EMA at $4.54.
If the price keeps falling, the next level below is the 52-week low at $3.80. With the RSI in the bearish zone, momentum still leans lower.
Technical indicators
Momentum and trend for QS, from its daily closes.
As of October 17, 2026, with QS at $4.02, its 14-day RSI is 31.1 (showing bearish momentum without being oversold), its 50-day simple moving average is $5.22 and its 200-day is $6.99.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What QS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, QS's 1-year correlation of daily returns is +0.39 with S&P 500 (SPY), +0.43 with Nasdaq 100 (QQQ), +0.40 with Bitcoin (BTC) and +0.20 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
0 of 9 analysts rate it a buy or strong buy, 7 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $7.50 is 86.6% above the price.More buy ratings than three months ago ›
0 of 9 rate it a buy now, against 0 of 9 three months ago.
QS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 24, 2026 | TD Cowen | Maintains | Hold |
As of October 17, 2026, 9 Wall Street analysts cover QS: 0 rate it a buy or strong buy, 7 a hold and 2 a sell or strong sell. Their 12-month price targets range from $2.50 to $10.00, with a median of $7.50, 86.6% above the price of $4.02.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
QS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
QS moves about 3.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much QS tends to move, against the market and on its own.
The long record
QS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.18% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 96.9%, from December 2020 to April 2025; the price is still 96.4% below that peak.Most 1-year holds ended higher ›
28% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in August 2020 is now worth $4,060.61, against $24,583 in the S&P 500 (SPY).
QS Drawdowns & Recovery
As of October 17, 2026, QS's worst peak-to-trough fall over the last 6 years with dividends reinvested was -96.9% (December 2020 to April 2025); it is still 96.4% below that peak, and 28% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into QS in August 2020 is worth now, against the same amount in the S&P 500.
Against the market: QS trailed the S&P 500 over this period: $4,060.61 against $24,583.
A $10,000 investment in QS in August 2020 would be worth about $4,061 today with dividends reinvested, compared with about $24,583 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to QS, and which have not.
Strongest month, December: an average of +44.49%, up in 3 of 6 years.
Weakest month, August: an average of -12.08%, up in 2 of 6 years.
This month, October: has averaged -3.44%, up in 2 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, QS's strongest calendar month has been December (average +44.49%, up in 3 of 6 years) and its weakest August (average -12.08%, up in 2 of 6 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in QS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in QS today could grow to about $6,172 by 2036 in the base case, with a 90th-percentile outcome near $46,826 and a 10th-percentile outcome around $814. Projections are statistical simulations, not guarantees.
QS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $3.31 for QS by 2030 in the base case, from $4.02 today (0.8x over 4 years). The 10th-percentile path ends near $0.92. These are outcomes of a Monte Carlo simulation run on QS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $2.02 | $3.83 | $7.27 | |
| 2028 | $1.47 | $3.65 | $9.03 | |
| 2029 | $1.15 | $3.48 | $10.55 | |
| 2030 | $0.92 | $3.31 | $11.94 | |
| 2031 | $0.7536 | $3.16 | $13.24 |
Method: a lognormal simulation of QS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
QS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought QS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, QS insiders reported 58 open-market sales worth $142.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 120.0K | $544.8K |
| Oct 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 59.2K | - |
| Sep 15, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 120.0K | $610.5K |
| Sep 15, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 45.0K | - |
| Aug 21, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 12.7K | $76.5K |
| Aug 21, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 12.7K | - |
| Aug 19, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 41.9K | $241.1K |
| Aug 19, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 21.5K | - |
| Jul 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 137.2K | $999.6K |
| Jul 2, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $71.4K |
| Jul 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 137.2K | - |
| Jun 22, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $77.8K |
| Jun 3, 2026 | Bradley W Buss
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Jeneanne Michelle Hanley
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Gena C. Lovett
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Ross Niebergall
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Geoffrey George Ribar
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Dipender Saluja
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Dennis Lynn Segers
Director
|
Grant | 24.2K | - |
| Jun 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 190.9K | $1.8M |
| Jun 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 190.9K | - |
| May 21, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 118.4K | $974.9K |
| May 21, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $79.0K |
| May 21, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 118.4K | - |
| May 20, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 184.4K | $1.4M |
| May 20, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| May 12, 2026 | Jeffrey B Straubel
Director
|
Sell | 27.1K | $212.9K |
| May 6, 2026 | Mohit Singh
Officer
|
Sell | 50.0K | $393.7K |
| Apr 30, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 212.1K | - |
| Apr 14, 2026 | Luca Giovanni Fasoli
Chief Operating Officer
|
Grant | 801.2K | - |
| Apr 14, 2026 | Kevin Hettrich
Chief Financial Officer
|
Grant | 516.3K | - |
| Apr 14, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 658.8K | - |
| Apr 14, 2026 | Michael Owen Mccarthy III
Officer
|
Grant | 623.1K | - |
| Apr 14, 2026 | Mohit Singh
Officer
|
Grant | 623.1K | - |
| Apr 14, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 1.8M | - |
| Apr 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 161.3K | $996.6K |
| Apr 2, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $167.2K |
| Apr 2, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $60.8K |
| Apr 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Mar 11, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $188.4K |
| Mar 11, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $68.1K |
| Mar 6, 2026 | Michael Owen Mccarthy III
Officer
|
Sell | 75.0K | $510.0K |
| Mar 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 161.3K | $1.1M |
| Mar 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Mar 4, 2026 | Ross S. Niebergall
Director
|
Grant | 47.4K | - |
| Feb 24, 2026 | Luca Giovanni Fasoli
Chief Operating Officer
|
Grant | 26.4K | - |
| Feb 24, 2026 | Kevin Hettrich
Chief Financial Officer
|
Grant | 41.2K | - |
| Feb 24, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 42.3K | - |
| Feb 24, 2026 | Michael Owen Mccarthy III
Officer
|
Grant | 42.0K | - |
| Feb 24, 2026 | Mohit Singh
Officer
|
Grant | 42.3K | - |
| Feb 24, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 146.0K | - |
| Feb 23, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $66.2K |
| Feb 20, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 195.5K | $1.4M |
| Feb 19, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $192.5K |
| Feb 19, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Jan 29, 2026 | Geoffrey George Ribar
Director
|
Grant | 36.1K | - |
| Jan 14, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $103.8K |
| Jan 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $2.4M |
| Jan 5, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $305.7K |
| Jan 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Dec 19, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $1.8M |
| Dec 19, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Dec 15, 2025 | Dipender Saluja
Director
|
Sell | 3.3M | $36.9M |
| Dec 15, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $108.5K |
| Dec 15, 2025 | Gena C. Lovett
Director
|
Grant | 3.4K | - |
| Dec 4, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $2.7M |
| Dec 4, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Nov 25, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 76.4K | $894.2K |
| Nov 25, 2025 | Michael Owen Mccarthy III
Officer
|
Grant | 76.4K | - |
| Nov 21, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $110.7K |
| Nov 19, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 246.7K | $3.1M |
| Nov 19, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Nov 7, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 20.4K | $329.4K |
| Nov 7, 2025 | Michael Owen Mccarthy III
Officer
|
Grant | 158.3K | - |
| Nov 5, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $2.7M |
| Nov 5, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Oct 31, 2025 | Bradley W Buss
Director
|
Sell | 300.0K | $5.4M |
| Oct 31, 2025 | Bradley W Buss
Director
|
Option | 300.0K | $1.9M |
| Oct 30, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 50.0K | $789.0K |
| Oct 30, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 50.0K | $118.9K |
| Oct 27, 2025 | Srinivasan Sivaram
Chief Executive Officer
|
Sell | 120.0K | $2.0M |
| Oct 24, 2025 | Friedrich Prinz
Director
|
Sell | 1.0M | $15.5M |
| Oct 24, 2025 | Bradley W Buss
Director
|
Sell | 400.0K | $6.3M |
| Oct 24, 2025 | Mohit Singh
Officer
|
Sell | 220.0K | $3.3M |
| Oct 24, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 46.3K | $706.0K |
| Oct 24, 2025 | Bradley W Buss
Director
|
Option | 400.0K | $2.5M |
| Oct 24, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 25.0K | $59.4K |
| Oct 24, 2025 | Friedrich Prinz
Director
|
Grant | 980.9K | - |
| Oct 24, 2025 | Mohit Singh
Officer
|
Option | 63.0K | $149.7K |
| Oct 3, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $3.3M |
| Oct 3, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 153.6K | - |
| Oct 1, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $2.2M |
| Oct 1, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $136.6K |
| Oct 1, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Sep 12, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $1.4M |
| Sep 12, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 38.0K | $347.3K |
| Sep 12, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $90.2K |
| Sep 12, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Sep 8, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 244.5K | $1.9M |
| Sep 8, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 44.9K | - |
| Aug 19, 2025 | Mohit Singh
Officer
|
Sell | 23.6K | $204.2K |
| Jul 25, 2025 | Friedrich Prinz
Director
|
Sell | 1.0M | $11.6M |
| Jul 25, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 500.0K | $5.8M |
| Jul 25, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 300.0K | $713.1K |
| Jul 25, 2025 | Friedrich Prinz
Director
|
Grant | 498.0K | - |
| Jul 16, 2025 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 450.0K | - |
| Jul 8, 2025 | Mohit Singh
Officer
|
Sell | 465.0K | $3.8M |
| Jul 8, 2025 | Mohit Singh
Officer
|
Option | 465.0K | $939.0K |
| Jul 7, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 511.8K | $3.6M |
| Jul 3, 2025 | Friedrich Prinz
Director
|
Sell | 864.7K | $6.1M |
| Jul 3, 2025 | Timothy Holme
Chief Technology Officer
|
Option | 356.0K | $261.9K |
| Jun 26, 2025 | Mohit Singh
Officer
|
Sell | 615.0K | $4.1M |
| Jun 26, 2025 | Mohit Singh
Officer
|
Option | 615.0K | $1.1M |
| Jun 4, 2025 | Bradley W Buss
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Jeneanne Michelle Hanley
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Gena C. Lovett
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Dipender Saluja
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Dennis Lynn Segers
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Jeffrey Brian Straubel
Director
|
Grant | 48.2K | - |
| May 22, 2025 | Friedrich Prinz
Director
|
Sell | 61.5K | $242.2K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.